As trio of companies enter IPO queue, four more propose terms

Cross-border licensing company Everest, gene therapy play Freeline and oncology company Checkmate are the latest companies to enter the IPO queue, joining a long list of companies aspiring to go public in a season when investors have shown considerable appetite for

Read the full 417 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers